FOLH1 and glioblastoma: At the moment, only a few studies evaluating PSMA targeted imaging of HGG in clinical practice have been performed, but they could confirm that HGG/glioblastoma are PSMA-avid compared to low-grade tumours (Valtorta et al. 2020).